1. Home
  2. JTAI vs ALBT Comparison

JTAI vs ALBT Comparison

Compare JTAI & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jet.AI Inc.

JTAI

Jet.AI Inc.

HOLD

Current Price

$0.30

Market Cap

4.6M

Sector

Finance

ML Signal

HOLD

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.83

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JTAI
ALBT
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JTAI
ALBT
Price
$0.30
$0.83
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
28.7M
115.8K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,584,279.00
$1,611,940.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.80
52 Week High
$11.77
$11.66

Technical Indicators

Market Signals
Indicator
JTAI
ALBT
Relative Strength Index (RSI) 26.40 27.76
Support Level $0.26 $0.80
Resistance Level $0.43 $1.19
Average True Range (ATR) 0.11 0.10
MACD 0.02 -0.03
Stochastic Oscillator 3.72 0.92

Price Performance

Historical Comparison
JTAI
ALBT

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: